Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biopharma Largely Avoids Partisan Bloodbath At US Pricing Hearing

Jun 14 2017

• By Michael Cipriano

Capitol House

Related Content

FDA User Fee Bill: House Cmte. Makes Technical Changes, Adds Pricing Resolution

Jun 08 2017

Drug Pricing 'Deeper Dive' Planned By Senate Cmte. As Industry Avoids First Blood

Jun 14 2017

REMS Could Block ANDAs With 'Legitimate Business Justification' In Senate Bill

Apr 30 2017

Additional Topics

United States Pricing Debate Reimbursement Policy BioPharmaceutical

More from Drug Pricing

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window